| Metric | FY 2107↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.26 | $1.92 | $1.43 | $1.44 | $2.79 | $0.72 | $0.52 | $0.46 |
| EPS (Diluted) | $0.26 | $1.92 | $1.42 | $1.44 | $2.76 | $0.71 | $0.52 | $0.46 |
| Metric | FY 2107↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1B | $4.1B | $4.0B | $3.8B | $3.6B | $3.5B | $3.2B | $2.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.9B | $3.9B | $3.8B | $3.6B | $3.4B | $3.2B | $3.0B | $2.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B |
| Metric | FY 2107↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B |
| Investing Cash Flow | — | $0.1B | $-0.0B | $-0.2B | $-0.4B | $-0.5B | $-0.4B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | — | $0.1B | $0.2B | $0.2B | $0.1B | $0.3B | $0.7B | $0.1B |